Wu, Jackson

Radiation Oncology

Clinical Associate Professor

MD, FRCPC

Biography

Dr. Jackson Wu is a radiation oncologist.  He completed undergraduate medical and residency training at University of British Columbia (UBC) in Vancouver in 1998, after which he received training as a clinical fellow at the Princess Margaret Hospital, University of Toronto, until 2000 when he became consultant radiation oncologist at the Hamilton Regional Cancer Centre in Hamilton, Ontario.  He moved to Calgary in 2002 to continue his career in the Division of Radiation Oncology at the Tom Baker Cancer Centre, where he participated in and conducted clinical trial projects in the treatment of prostate cancer and metastatic bone pain, and served on committees related to oncology education and research administration.

Career highlights include serving as a Royal College examiner in radiation oncology (2005-2009), as a grant reviewer in CIHR Randomized Controlled Trials Committee (2014-2020), as a departmental liaison with the Calgary Zone Medical Assistance in Dying Care Coordination Service (2017-2020), and as a vice chair on the Health Research Ethics Board of Alberta Cancer Committee (2014-ongoing).  Life-changing experiences include a midcareer leave-of-absence for an immersive year of studies at the University of Toronto towards a master degree in clinical epidemiology (biostatistics and research methods).  His favorite quote is: “Science is the belief in the ignorance of experts.” (Richard Feynman).

Main hobby is music appreciation through high resolution stereo playback systems.  He is married to a full time obstetrician-gynecologist.

Area of Focus

Summary of Research

Key Publications:

  1. Wu JSY, Pinilla J, Watson M, Verma S, Olivotto IA. Medical assistance in dying for cancer patients one year after legalization: a Collaborative approach at a Comprehensive Cancer Centre.  Current Oncology 2018; 25(5).  https://doi.org/10.3747/co.25.4118
  2. Catton CN, Lukka H, Gu CS, Martin JM, Supiot S, Chung PWM, et al. Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer. (OCOG PROFIT Study NCT00304759.)  J Clin Oncol 2017 Jun 10; 35(17):1884-90
  3. Mcdonald R, Ding K, Brundage M, Meyer RM, Nabid A, Chabot P, et al. Effect of radiotherapy on painful bone metastases: a secondary analysis of the NCIC clinical trial group symptom control trial.  JAMA Oncol. 2017 Feb 09.
  4. Grendarova P, Sinnarajah A, Trotter T, Card C, and Wu JSY. Variations in intensity of end-of-life cancer therapy by cancer type at a Canadian tertiary cancer centre between 2003-2010.  Support Care Cancer. 2015 Oct 01;23(10):3059-67
  5. Wu JSY, Brasher P, El-Gayed A, Pervez N, Tai P, Robinson J, et al. Phase II Study of Hypofractionated Image-Guided Radiotherapy for Localized Prostate Cancer: Outcomes of 55 Gy in 16 Fractions at 3.4 Gy per Fraction.  Radiother Oncol. 2012 May 01;103(2):210-6.

Book Chapters

Wu, JSY (2016).  ‘Methodological Issues and Challenges in Performing Clinical Trials in Palliative Radiotherapy’, in Fairchild A.M. (ed.)  Palliative Radiation Therapy – Utilization of Advanced Technologies.  New York: Nova Science Publishers, pp.113-134.

Area Of Focus

Summary Of Research

Key Publications:

  1. Wu JSY, Pinilla J, Watson M, Verma S, Olivotto IA. Medical assistance in dying for cancer patients one year after legalization: a Collaborative approach at a Comprehensive Cancer Centre.  Current Oncology 2018; 25(5).  https://doi.org/10.3747/co.25.4118
  2. Catton CN, Lukka H, Gu CS, Martin JM, Supiot S, Chung PWM, et al. Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer. (OCOG PROFIT Study NCT00304759.)  J Clin Oncol 2017 Jun 10; 35(17):1884-90
  3. Mcdonald R, Ding K, Brundage M, Meyer RM, Nabid A, Chabot P, et al. Effect of radiotherapy on painful bone metastases: a secondary analysis of the NCIC clinical trial group symptom control trial.  JAMA Oncol. 2017 Feb 09.
  4. Grendarova P, Sinnarajah A, Trotter T, Card C, and Wu JSY. Variations in intensity of end-of-life cancer therapy by cancer type at a Canadian tertiary cancer centre between 2003-2010.  Support Care Cancer. 2015 Oct 01;23(10):3059-67
  5. Wu JSY, Brasher P, El-Gayed A, Pervez N, Tai P, Robinson J, et al. Phase II Study of Hypofractionated Image-Guided Radiotherapy for Localized Prostate Cancer: Outcomes of 55 Gy in 16 Fractions at 3.4 Gy per Fraction.  Radiother Oncol. 2012 May 01;103(2):210-6.

Book Chapters

Wu, JSY (2016).  ‘Methodological Issues and Challenges in Performing Clinical Trials in Palliative Radiotherapy’, in Fairchild A.M. (ed.)  Palliative Radiation Therapy – Utilization of Advanced Technologies.  New York: Nova Science Publishers, pp.113-134.